NCT05253131 2026-02-11Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for SarcomasUniversity of Alabama at BirminghamPhase 2 Not yet recruiting41 enrolled
NCT06735820 2025-07-03MEKMDM2Children's National Research InstitutePhase 1/2 Not yet recruiting45 enrolled